nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—SLCO1B1—Rifampicin—leprosy	0.456	0.479	CbGbCtD
Repaglinide—CYP2C8—Rifampicin—leprosy	0.193	0.203	CbGbCtD
Repaglinide—CYP2C8—Dapsone—leprosy	0.159	0.167	CbGbCtD
Repaglinide—CYP3A4—Rifampicin—leprosy	0.0783	0.0823	CbGbCtD
Repaglinide—CYP3A4—Dapsone—leprosy	0.0646	0.0679	CbGbCtD
Repaglinide—Tooth disorder—Thalidomide—leprosy	0.00236	0.0543	CcSEcCtD
Repaglinide—Myocardial ischaemia—Thalidomide—leprosy	0.00191	0.0438	CcSEcCtD
Repaglinide—Pancreatitis—Dapsone—leprosy	0.00184	0.0423	CcSEcCtD
Repaglinide—Sinusitis—Dapsone—leprosy	0.00157	0.0361	CcSEcCtD
Repaglinide—Erythema—Dapsone—leprosy	0.00131	0.0301	CcSEcCtD
Repaglinide—Cardiac failure congestive—Thalidomide—leprosy	0.00123	0.0282	CcSEcCtD
Repaglinide—PPARG—hindlimb—leprosy	0.00118	0.245	CbGeAlD
Repaglinide—Visual disturbance—Thalidomide—leprosy	0.00117	0.027	CcSEcCtD
Repaglinide—Hypoglycaemia—Thalidomide—leprosy	0.00114	0.0262	CcSEcCtD
Repaglinide—PPARG—appendage—leprosy	0.00102	0.21	CbGeAlD
Repaglinide—Pancreatitis—Thalidomide—leprosy	0.000943	0.0217	CcSEcCtD
Repaglinide—Angina pectoris—Thalidomide—leprosy	0.000936	0.0215	CcSEcCtD
Repaglinide—Bronchitis—Thalidomide—leprosy	0.000925	0.0213	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dapsone—leprosy	0.000873	0.0201	CcSEcCtD
Repaglinide—Hyperglycaemia—Thalidomide—leprosy	0.000867	0.0199	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00085	0.0195	CcSEcCtD
Repaglinide—Acute coronary syndrome—Thalidomide—leprosy	0.000845	0.0194	CcSEcCtD
Repaglinide—Abdominal pain—Dapsone—leprosy	0.000844	0.0194	CcSEcCtD
Repaglinide—Myocardial infarction—Thalidomide—leprosy	0.00084	0.0193	CcSEcCtD
Repaglinide—Sinusitis—Thalidomide—leprosy	0.000804	0.0185	CcSEcCtD
Repaglinide—Rhinitis—Thalidomide—leprosy	0.000771	0.0177	CcSEcCtD
Repaglinide—Hepatitis—Thalidomide—leprosy	0.000769	0.0177	CcSEcCtD
Repaglinide—Oedema peripheral—Thalidomide—leprosy	0.000758	0.0174	CcSEcCtD
Repaglinide—Visual impairment—Thalidomide—leprosy	0.000742	0.017	CcSEcCtD
Repaglinide—Erythema multiforme—Thalidomide—leprosy	0.000728	0.0167	CcSEcCtD
Repaglinide—Eye disorder—Thalidomide—leprosy	0.000719	0.0165	CcSEcCtD
Repaglinide—Cardiac disorder—Thalidomide—leprosy	0.000714	0.0164	CcSEcCtD
Repaglinide—Immune system disorder—Thalidomide—leprosy	0.000695	0.016	CcSEcCtD
Repaglinide—Arrhythmia—Thalidomide—leprosy	0.000687	0.0158	CcSEcCtD
Repaglinide—Alopecia—Thalidomide—leprosy	0.00068	0.0156	CcSEcCtD
Repaglinide—Vomiting—Dapsone—leprosy	0.000679	0.0156	CcSEcCtD
Repaglinide—Malnutrition—Thalidomide—leprosy	0.00067	0.0154	CcSEcCtD
Repaglinide—Headache—Dapsone—leprosy	0.000669	0.0154	CcSEcCtD
Repaglinide—Back pain—Thalidomide—leprosy	0.000648	0.0149	CcSEcCtD
Repaglinide—Nausea—Dapsone—leprosy	0.000634	0.0146	CcSEcCtD
Repaglinide—Leukopenia—Thalidomide—leprosy	0.0006	0.0138	CcSEcCtD
Repaglinide—Palpitations—Thalidomide—leprosy	0.000592	0.0136	CcSEcCtD
Repaglinide—Hypertension—Thalidomide—leprosy	0.000578	0.0133	CcSEcCtD
Repaglinide—Arthralgia—Thalidomide—leprosy	0.00057	0.0131	CcSEcCtD
Repaglinide—Chest pain—Thalidomide—leprosy	0.00057	0.0131	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000566	0.013	CcSEcCtD
Repaglinide—PPARG—blood vessel—leprosy	0.000566	0.117	CbGeAlD
Repaglinide—Oedema—Thalidomide—leprosy	0.000547	0.0126	CcSEcCtD
Repaglinide—Thrombocytopenia—Thalidomide—leprosy	0.000535	0.0123	CcSEcCtD
Repaglinide—Skin disorder—Thalidomide—leprosy	0.000531	0.0122	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Thalidomide—leprosy	0.000498	0.0114	CcSEcCtD
Repaglinide—Paraesthesia—Thalidomide—leprosy	0.000491	0.0113	CcSEcCtD
Repaglinide—Dyspepsia—Thalidomide—leprosy	0.000481	0.0111	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Thalidomide—leprosy	0.000472	0.0108	CcSEcCtD
Repaglinide—Constipation—Thalidomide—leprosy	0.000467	0.0107	CcSEcCtD
Repaglinide—Gastrointestinal pain—Thalidomide—leprosy	0.000447	0.0103	CcSEcCtD
Repaglinide—Urticaria—Thalidomide—leprosy	0.000434	0.00998	CcSEcCtD
Repaglinide—Abdominal pain—Thalidomide—leprosy	0.000432	0.00993	CcSEcCtD
Repaglinide—Hypersensitivity—Thalidomide—leprosy	0.000403	0.00926	CcSEcCtD
Repaglinide—Pruritus—Thalidomide—leprosy	0.000387	0.00889	CcSEcCtD
Repaglinide—Diarrhoea—Thalidomide—leprosy	0.000374	0.0086	CcSEcCtD
Repaglinide—Vomiting—Thalidomide—leprosy	0.000348	0.00799	CcSEcCtD
Repaglinide—Rash—Thalidomide—leprosy	0.000345	0.00792	CcSEcCtD
Repaglinide—Dermatitis—Thalidomide—leprosy	0.000344	0.00792	CcSEcCtD
Repaglinide—Headache—Thalidomide—leprosy	0.000342	0.00787	CcSEcCtD
Repaglinide—Nausea—Thalidomide—leprosy	0.000325	0.00746	CcSEcCtD
Repaglinide—KCNJ11—tendon—leprosy	0.000284	0.0587	CbGeAlD
Repaglinide—PPARG—skin of body—leprosy	0.000262	0.0542	CbGeAlD
Repaglinide—KCNJ11—nervous system—leprosy	0.00023	0.0477	CbGeAlD
Repaglinide—ABCC8—testis—leprosy	0.000216	0.0447	CbGeAlD
Repaglinide—ABCC8—nervous system—leprosy	0.000212	0.0439	CbGeAlD
Repaglinide—PPARG—tendon—leprosy	0.000199	0.0412	CbGeAlD
Repaglinide—PPARG—testis—leprosy	0.000165	0.0342	CbGeAlD
Repaglinide—PPARG—nervous system—leprosy	0.000162	0.0335	CbGeAlD
Repaglinide—ALB—testis—leprosy	0.000155	0.032	CbGeAlD
Repaglinide—CYP2C8—testis—leprosy	0.000109	0.0225	CbGeAlD
Repaglinide—CYP3A4—nervous system—leprosy	7.24e-05	0.015	CbGeAlD
